Docetaxel Anhydrous Structure (Docetaxel Injection Usp 1)
Docetaxel Injection, Solution, Concentrate
Product Images NDC 0143-9205
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Docetaxel (NDC 0143-9205). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 9 (Docetaxel Injection Usp 10)
This is a survival analysis where the time (in months) for an event to occur is being examined. The numbers 0, 6, 12, 16, and 26 may represent the time intervals at which data was collected or the survival times of individuals in a study. The symbols % and T2 have no clear context based on this information. The numbers 42, 45, 54, and 60 may represent the survival times or may be related to some other variable being examined in the study.*
Figure 10 (Docetaxel Injection Usp 11)
This appears to be a graph showing the survival probabilities for patients with various conditions over time. The X-axis represents the number of months since treatment began, while the Y-axis represents the probability of survival. The legend on the right side of the graph lists the different patient groups included in the data.*
20 mg/ 1ml Vial Label (Docetaxel Injection Usp 12)
80 mg/ 4 mL Vial Label (Docetaxel Injection Usp 13)
Thymoorgan Design 1 (Docetaxel Injection Usp 14)
This text appears to be a product label or code. It contains a Global Trade Item Number (GTIN) of 00301234567896, a serial number (SN) of 12345678901234, an expiration date expressed in the format YYYY-MMM, and a lot number of ABCDE12345. It is likely used for inventory or tracking purposes.*
Figure 1 (Docetaxel Injection Usp 2)
Figure 2 (Docetaxel Injection Usp 3)
This appears to be a table or a chart showing "Survival Probability (%)" values for different "Survival Time (months)" data points. However, without knowing the context or the source of the data, it is difficult to determine what this information pertains to or how it can be used.*
Figure 3 (Docetaxel Injection Usp 4)
This is a visualization of cumulative probability and overall survival for a certain period of time, possibly related to medical research. Cumulative probability is depicted as a graph with values ranging from 0 to 1, while a log-rank p-value of 0.010 suggests a statistically significant difference in overall survival. The x-axis shows survival time in months. The exact context and details are not available.*
Figure 4 (Docetaxel Injection Usp 5)
The given text represents a graph displaying the cumulative probability of survival over a period of time (in months). The graph provides an overall survival rate with a Log-rank p-value of 0.13. The x-axis represents the survival time (in months) while the y-axis represents the probability of survival.*
Figure 5 (Docetaxel Injection Usp 6)
This appears to be a graph or chart showing survival probability over different amounts of time (measured in months). The survival probability is not explicitly given but is likely represented by the curved line on the graph. The specific values for survival time shown are 9, 12, 15, 18, and 21 months, with the corresponding survival probability being shown on the y-axis. There are also vertical lines at 24 and 27 months. Without additional context or information, it is difficult to draw any conclusions about the data being presented.*
Figure 6 (Docetaxel Injection Usp 7)
Figure 7 (Docetaxel Injection Usp 8)
Figure 8 (Docetaxel Injection Usp 9)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
